As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop

The Firm is evaluating legal claims on behalf of women who experienced the spread of uterine sarcoma and other cancers, allegedly due to uterine morcellation. New York, New York (PRWEB) September 20, 2014 As concerns surrounding the use of power morcellators (http://www.injurybeacon.com/power-morcellator/) in gynecological surgeries continue to grow, Bernstein Liebhard LLP notes that yet another insurer has announced plans to end coverage for uterine morcellation. According to a statement posted on its website last month, Harrisburg, Pennsylvania-based Capital BlueCross will end coverage
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories